Active, not recruiting
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
NCT05948475
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- UCLA Medical Center Santa Monica, California, United States
- Stanford Cancer Center Stanford, California, United States
- The University of Kansas Cancer Center Westwood, Los Angeles, California, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States